Previous Close | 24.51 |
Open | 23.20 |
Bid | 21.78 x 63700 |
Ask | 22.23 x 61200 |
Day's Range | 23.20 - 23.20 |
52 Week Range | 19.40 - 31.60 |
Volume | |
Avg. Volume | 17 |
Market Cap | 2.415B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 26.36 |
EPS (TTM) | 0.88 |
Earnings Date | Jul 31, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 25.25 |
Corcept Therapeutics ( NASDAQ:CORT ) First Quarter 2024 Results Key Financial Results Revenue: US$146.8m (up 39% from...
Corcept (CORT) beats on both earnings and sales in the first quarter of 2024. The company increases revenue guidance for 2024.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript May 1, 2024 Corcept Therapeutics Incorporated beats earnings expectations. Reported EPS is $0.2503, expectations were $0.21. Corcept Therapeutics Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank […]